Bo-Göran Ericzon

2.1k total citations · 1 hit paper
15 papers, 912 citations indexed

About

Bo-Göran Ericzon is a scholar working on Surgery, Hepatology and Molecular Biology. According to data from OpenAlex, Bo-Göran Ericzon has authored 15 papers receiving a total of 912 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Surgery, 7 papers in Hepatology and 5 papers in Molecular Biology. Recurrent topics in Bo-Göran Ericzon's work include Organ Transplantation Techniques and Outcomes (5 papers), Pancreatic function and diabetes (4 papers) and Liver Disease and Transplantation (3 papers). Bo-Göran Ericzon is often cited by papers focused on Organ Transplantation Techniques and Outcomes (5 papers), Pancreatic function and diabetes (4 papers) and Liver Disease and Transplantation (3 papers). Bo-Göran Ericzon collaborates with scholars based in Sweden, France and United States. Bo-Göran Ericzon's co-authors include Yukio Ando, John L. Berk, Violaine Planté‐Bordeneuve, Claudio Rapezzi, W. David Lewis, Fabrizio Salvi, Márcia Waddington‐Cruz, Shu-ichi Ikeda, Laura Obici and Gérard Saïd and has published in prestigious journals such as Hepatology, Journal of Hepatology and Transplantation.

In The Last Decade

Bo-Göran Ericzon

15 papers receiving 894 citations

Hit Papers

Guideline of transthyretin-related hereditary amyloidosis... 2013 2026 2017 2021 2013 100 200 300 400
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Guideline of transthyretin-related hereditary amyloidosis for clinicians
    2013 493 citations Yukio Ando, Teresa Coelho et al. Orphanet Journal of Rare Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bo-Göran Ericzon Sweden 10 608 219 206 145 134 15 912
Claudia de Toma France 11 255 0.4× 157 0.7× 99 0.5× 41 0.3× 87 0.6× 18 1.2k
Catharina G. K. Wichers Netherlands 13 254 0.4× 109 0.5× 157 0.8× 55 0.4× 133 1.0× 18 619
M.R. Persey United Kingdom 6 563 0.9× 130 0.6× 88 0.4× 22 0.2× 72 0.5× 13 658
Daniel Guldager Kring Rasmussen Denmark 15 148 0.2× 114 0.5× 56 0.3× 153 1.1× 255 1.9× 45 777
Arnaud Marlier United States 19 453 0.7× 147 0.7× 83 0.4× 62 0.4× 40 0.3× 26 930
S. Madhoo United Kingdom 9 464 0.8× 112 0.5× 65 0.3× 14 0.1× 58 0.4× 17 577
Prayman Sattianayagam United Kingdom 13 968 1.6× 133 0.6× 236 1.1× 7 0.0× 164 1.2× 27 1.1k
V.M. Factor United States 2 270 0.4× 131 0.6× 49 0.2× 147 1.0× 51 0.4× 2 516
Ewelina Kulikowski United States 19 771 1.3× 169 0.8× 159 0.8× 24 0.2× 58 0.4× 49 1.2k
Julie Goswami United States 11 216 0.4× 151 0.7× 168 0.8× 142 1.0× 180 1.3× 27 790

Countries citing papers authored by Bo-Göran Ericzon

Since Specialization
Citations

This map shows the geographic impact of Bo-Göran Ericzon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bo-Göran Ericzon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bo-Göran Ericzon more than expected).

Fields of papers citing papers by Bo-Göran Ericzon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bo-Göran Ericzon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bo-Göran Ericzon. The network helps show where Bo-Göran Ericzon may publish in the future.

Co-authorship network of co-authors of Bo-Göran Ericzon

This figure shows the co-authorship network connecting the top 25 collaborators of Bo-Göran Ericzon. A scholar is included among the top collaborators of Bo-Göran Ericzon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bo-Göran Ericzon. Bo-Göran Ericzon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Domogatskaya, Anna, Masaaki Watanabe, Kazuaki Tokodai, et al.. (2021). Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation. Cell Transplantation. 30. 4211097595–4211097595. 6 indexed citations
2.
Watanabe, Masaaki, Kazuaki Tokodai, Anthony Cerami, et al.. (2020). Improvement of Islet Allograft Function Using Cibinetide, an Innate Repair Receptor Ligand. Transplantation. 104(10). 2048–2058. 5 indexed citations
3.
Tokodai, Kazuaki, Makiko Kumagai‐Braesch, Ahmad Karadagi, et al.. (2019). Blood Group Antigen Expression in Isolated Human Liver Cells in Preparation for Implementing Clinical ABO-Incompatible Hepatocyte Transplantation. Journal of Clinical and Experimental Hepatology. 10(2). 106–113. 7 indexed citations
4.
Tokodai, Kazuaki, et al.. (2019). Characteristics and risk factors for recurrence of nonalcoholic steatohepatitis following liver transplantation. Scandinavian Journal of Gastroenterology. 54(2). 233–239. 16 indexed citations
5.
Johansson, H, Meng Li, Ingemar Björkhem, et al.. (2017). Circulating Fibroblast Growth Factor 19 in Portal and Systemic Blood. Journal of Clinical and Experimental Hepatology. 8(2). 162–168. 13 indexed citations
6.
Gramignoli, Roberto, Veysel Tahan, Kenneth Dorko, et al.. (2013). New potential cell source for hepatocyte transplantation: Discarded livers from metabolic disease liver transplants. Stem Cell Research. 11(1). 563–573. 44 indexed citations
7.
Ando, Yukio, Teresa Coelho, John L. Berk, et al.. (2013). Guideline of transthyretin-related hereditary amyloidosis for clinicians. Orphanet Journal of Rare Diseases. 8(1). 31–31. 493 indexed citations breakdown →
8.
Stangou, Arie J., Luísa Lobato, Steven R. Zeldenrust, et al.. (2012). Solid organ transplantation for non-TTR hereditary amyloidosis: report from the 1st International Workshop on the Hereditary Renal Amyloidoses. Amyloid. 19(sup1). 81–84. 6 indexed citations
9.
Fischer, Lutz, Pavel Trunečka, Bruno Gridelli, et al.. (2010). Pharmacokinetics for once-daily versus twice-daily tacrolimus formulations in de novo liver transplantation: A randomized, open-label trial. Liver Transplantation. 17(2). 167–177. 48 indexed citations
10.
Okamoto, Sadahisa, Jonas Wixner, Konen Obayashi, et al.. (2009). Liver transplantation for familial amyloidotic polyneuropathy: Impact on Swedish patients' survival. Liver Transplantation. 15(10). 1229–1235. 97 indexed citations
11.
Rissler, Pehr, Tomas Nordman, Ling Xia, et al.. (2005). Adriamycin cytotoxicity may stimulate growth of hepatocellular tumours in an experimental model for adjuvant systemic chemotherapy in liver transplantation. Transplant International. 18(8). 992–1000. 2 indexed citations
12.
Leidenius, Marjut, K. Höckerstedt, Ulrika Broomé, et al.. (2001). Hepatobiliary carcinoma in primary sclerosing cholangitis: a case control study. Journal of Hepatology. 34(6). 792–798. 28 indexed citations
13.
Axelson, M., Ewa Ellis, Birgitta Mörk, et al.. (2000). Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid. Hepatology. 31(6). 1305–1312. 74 indexed citations
14.
Farges, Olivier, Bo-Göran Ericzon, Stephen V. Lynch, et al.. (1994). A RANDOMIZED TRIAL OF OKT3-BASED VERSUS CYCLOSPORINE-BASED IMMUNOPROPHYLAXIS AFTER LIVER TRANSPLANTATION. Transplantation. 58(8). 891–898. 24 indexed citations
15.
Ericzon, Bo-Göran, et al.. (1990). Characteristics of biliary lipid metabolism after liver transplantation. Hepatology. 12(5). 1222–1228. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claudia de Toma Breakdown of academic impact, for papers by Catharina G. K. Wichers Breakdown of academic impact, for papers by M.R. Persey Breakdown of academic impact, for papers by Daniel Guldager Kring Rasmussen Breakdown of academic impact, for papers by Arnaud Marlier Breakdown of academic impact, for papers by S. Madhoo Breakdown of academic impact, for papers by Prayman Sattianayagam Breakdown of academic impact, for papers by V.M. Factor Breakdown of academic impact, for papers by Ewelina Kulikowski Breakdown of academic impact, for papers by Julie Goswami
Rankless by CCL
2026